Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes

الملخص EN

This study is aimed at investigating the expression, clinical significance, and biological role of CPT1A in kidney renal clear cell carcinoma (KIRC).

We used the TCGA database and clinical pathology of tissue specimens to study the expression of CPT1A in KIRC.

The expression of CPT1A in the kidney cancer tissue was significantly lower than that in the normal tissue.

Survival curves demonstrated that the expression was correlated with prognosis in patients.

We used the plasmid transfection method to explore the biological role of CPT1A in renal cancer cells and performed CCK-8, wound healing, and Transwell invasion experiments.

The results demonstrated that CPT1A can inhibit the proliferation, migration, and invasion of renal cancer cells.

Subsequently, we employed a bioinformatics analysis to further elucidate the role of CPT1A.

The PPI network diagram was plotted, along with the coexpression diagram, between CPT1A and ten associated genes.

The heat map was plotted, and the hazard ratio analysis of these eleven genes in KIRC was performed.

Furthermore, the CPT1A, LPL, CPT2, and EHHADH genes were used to establish a reliable prognostic risk signature in KIRC.

GSEA analysis demonstrated that CPT1A modulates tumor development via a variety of biological pathways in KIRC.

We believe that CPT1A most likely suppresses tumor progression by employing tumor “slimming” in KIRC.

Collectively, the results indicate the potential of CPT1A as a novel prognostic indicator and potential therapeutic target in KIRC.